Form D Explorer
Nexo Therapeutics, Inc. · CIK 1955319

Report a data issueCitable research briefCompare issuerPrivate research collection

Nexo Therapeutics, Inc.

CIK 1955319 · Corporation · Inc. DELAWARE · LITTLETON, Colorado · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
0
Amendments
2
Activity
Sep 17, 2025
through Mar 27, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldSep 17, 2025 · D/AMar 27, 2026 · D/ALater minus earlier
Reported offering amount$60,000,000$60,000,000$0
Reported amount sold$52,500,001$60,000,000$7,499,999
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001955319-25-000002 · Later SEC source: 0001955319-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Mar 27, 2026

Reported offering amount
$60,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$60,000,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)